Abstract
3-Methyladenine (3-MA), a well-known inhibitor of autophagic sequestration, can also prevent class III phosphatidylinositide (PI) 3-kinase activity, which is required for many processes in endosomal membrane trafficking. Although much is known about the effects of other PI 3-kinase inhibitors, such as wortmannin and LY294002, on endosomal membrane trafficking, little is known about those of 3-MA. Here we show that the treatment of cells with 3-MA results in a specific redistribution of the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor (MPR300) from the trans-Golgi network (TGN) to early/recycling endosomal compartments containing internalized transferrin. Importantly, in contrast to wortmannin and LY294002, 3-MA did not cause the enlargement of late endosomal/lysosomal compartments. The results suggest that the effect of 3-MA is restricted to the retrieval of MPR300 from early/recycling endosomes.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenine / analogs & derivatives*
-
Adenine / chemistry
-
Adenine / pharmacology*
-
Androstadienes / pharmacology
-
Animals
-
Biological Transport
-
Cations / metabolism
-
Cell Line
-
Chromones / pharmacology
-
Endosomes / metabolism*
-
Enzyme Inhibitors / pharmacology
-
Liver / metabolism
-
Lysosomes / metabolism
-
Mannosephosphates / metabolism*
-
Microscopy, Fluorescence
-
Morpholines / pharmacology
-
Phosphatidylinositol 3-Kinases / metabolism
-
Rats
-
Receptor, IGF Type 2 / antagonists & inhibitors
-
Receptor, IGF Type 2 / chemistry*
-
Receptor, IGF Type 2 / metabolism*
-
Subcellular Fractions / metabolism
-
Time Factors
-
Transferrin / metabolism
-
Wortmannin
-
trans-Golgi Network / metabolism*
Substances
-
Androstadienes
-
Cations
-
Chromones
-
Enzyme Inhibitors
-
MPR300 protein, rat
-
Mannosephosphates
-
Morpholines
-
Receptor, IGF Type 2
-
Transferrin
-
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
-
3-methyladenine
-
Phosphatidylinositol 3-Kinases
-
Adenine
-
Wortmannin